A large percentage of sera from chronically HCV infected patients or vaccinee sera bind to HCV envelope glycoproteins, but fail to efficiently neutralize infection, and some of these serum antibodies as well as human monoclonal antibodies enhance pseudotype infectious titer [17], [18], [19], [20], [21]. The gene discussed is ERVW-1; the disease is infection.